Deutsche Bank’s TriSalus Life Sciences TLSI Stock Holding History

Deutsche Bank’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$221K	Buy	48,523 +19,852	+69%	+$78.9K	﹤0.01%	3199
2026 Q1	$115K	Buy	28,671 +5,125	+22%	+$25.1K	﹤0.01%	3216
2025 Q4	$164K	Buy	+23,546	New	+$132K	﹤0.01%	3105
2025 Q3	–	Sell	-19,288	Closed	-$105K	–	3735
2025 Q2	$105K	Buy	+19,288	New	+$103K	﹤0.01%	3231

Other funds holding TLSI

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Cerity Partners New York $82.7B AUM 28.53% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $9.69B AUM 55.7% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

WPC

White Pine Capital Bloomington, Minnesota $423M AUM 67.01% 1-Year Est. Return

TSW

Thompson Siegel & Walmsley Richmond, Virginia $5.57B AUM 9.46% 1-Year Est. Return

Deutsche Bank's TLSI Position: Q2 2026 in Review

Deutsche Bank increased its TriSalus Life Sciences (TLSI) stake by 69% in Q2 2026, buying an estimated $78.9K and bringing the position to 48,523 shares worth $221K. The position accounts for ﹤0.01% of the portfolio, ranked #3199.

Deutsche Bank first reported a position in TLSI in Q2 2025 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold TLSI as of Q2 2026.

Deutsche Bank held 48,523 shares of TriSalus Life Sciences worth $221K as of Q2 2026.
Deutsche Bank bought 19,852 TriSalus Life Sciences shares in Q2 2026, an estimated $78.9K.
TriSalus Life Sciences made up ﹤0.01% of Deutsche Bank's portfolio in Q2 2026, its #3199 holding.
Deutsche Bank first reported a position in TriSalus Life Sciences in Q2 2025 and has held it in 4 quarters since.
78 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2026.

Based on Deutsche Bank's 13F filing for Q2 2026, filed 7 Aug 2026.